- Home
- EWTX vs BWLP Comparison
EWTX vs BWLP Comparison
Compare EWTX & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EWTX | BWLP |
|---|---|---|
| Founded | 2017 | 1935 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | EWTX | BWLP |
|---|---|---|
| Price | $28.57 | $15.98 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $34.71 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 445.0K |
| Earning Date | 03-02-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 8.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | N/A | ★ $3,693,482,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.16 |
| P/E Ratio | ★ N/A | $14.05 |
| Revenue Growth | N/A | ★ 2.54 |
| 52 Week Low | $10.60 | $7.86 |
| 52 Week High | $30.48 | $16.60 |
Technical Indicators
Market Signals| Indicator | EWTX | BWLP |
|---|---|---|
| Relative Strength Index (RSI) | 56.47 | 75.66 |
| Support Level | $27.07 | $15.22 |
| Resistance Level | $29.98 | $16.04 |
| Average True Range (ATR) | 1.54 | 0.35 |
| MACD | -0.06 | 0.14 |
| Stochastic Oscillator | 61.43 | 96.89 |
Price Performance
Historical ComparisonAbout EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About BWLP BW LPG Limited
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.